Compare ASB & APGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ASB | APGE |
|---|---|---|
| Founded | 1861 | 2022 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.7B | 4.7B |
| IPO Year | 2014 | 2023 |
| Metric | ASB | APGE |
|---|---|---|
| Price | $30.92 | $134.97 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 12 | 13 |
| Target Price | $29.75 | ★ $109.67 |
| AVG Volume (30 Days) | ★ 1.3M | 1.2M |
| Earning Date | 04-23-2026 | 05-12-2026 |
| Dividend Yield | ★ 3.45% | N/A |
| EPS Growth | ★ 284.72 | N/A |
| EPS | ★ 1.33 | N/A |
| Revenue | ★ $1,102,756,000.00 | N/A |
| Revenue This Year | $21.24 | N/A |
| Revenue Next Year | $8.86 | N/A |
| P/E Ratio | $23.16 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $23.86 | $35.39 |
| 52 Week High | $32.46 | $134.99 |
| Indicator | ASB | APGE |
|---|---|---|
| Relative Strength Index (RSI) | 48.23 | 77.86 |
| Support Level | $29.92 | $134.03 |
| Resistance Level | $31.77 | N/A |
| Average True Range (ATR) | 0.47 | 0.13 |
| MACD | -0.13 | -0.49 |
| Stochastic Oscillator | 28.02 | 93.56 |
Associated Banc-Corp is a bank holding company based in the United States of America. The company, through its subsidiaries, provides a broad array of banking and non-banking products and services to individuals and businesses. The group operates in three reportable segments: Corporate and Commercial Specialty; Community, Consumer, and Business; and Risk Management and Shared Services. The majority of its revenue is derived from the Corporate and Commercial Specialty segment, which serves a wide range of customers, including larger businesses, developers, not-for-profits, municipalities, and financial institutions by providing lending and deposit solutions as well as support to deliver, fund, and manage such banking solutions.
Apogee Therapeutics Inc is a clinical-stage biotechnology company engaged in advancing optimized, novel biologics with the potential for differentiated efficacy and dosing in the inflammatory and immunology (I&I) markets, including for the treatment of atopic dermatitis (AD), asthma, eosinophilic esophagitis (EoE), chronic obstructive pulmonary disease (COPD), and other I&I indications. . Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.